Transcatheter arterial chemoembolization combined with low-dose apatinib in the treatment of unresectable hepatocellular carcinoma in elderly patients: Efficacy and safety

Conclusions: TACE combined with low-dose apatinib provides an alternative treatment option for elderly patients with unresectable HCC. Our clinical study has proven its safety and efficacy.

Source: Journal of Cancer Research and Therapeutics - September 28, 2020 Category: Cancer & Oncology Authors: Song Liu Guangsheng Zhao Guangji Yu Nannan Guo Yuewei Zhang Qiang Li Zhe Wang Source Type: research